Funding for this research was provided by:
Canadian Child Health Clinician Scientist Program
Canadian Institutes of Health Research
Canadian Partnership Against Cancer
Garron Family Cancer Center
Text and Data Mining valid from 2019-03-01
Received: 12 April 2018
Accepted: 19 February 2019
First Online: 1 March 2019
Ethics approval and consent to participate
: The study was approved by the Hospital for Sick Children Research Ethics Board (#1000047116); Health Research Ethics Board of Alberta – Cancer Committee (HREBA.CC-15-0015); University of British Columbia Children’s and Women’s Research Ethics Board (H15–00093); University of Manitoba (E2015:005); Children’s Hospital of Eastern Ontario Research Ethics Board (#15/11E); Nova Scotia District Health Authorities Multisite Research Ethics Board (#100267); Newfoundland and Labrador Health Research Ethics Board (#15.031); Queen’s University Health Sciences & Affiliation Teaching Hospitals Research Ethics Board (PAED-374-15); Western University Health Science Research Ethics Board (#106358); Hamilton Integrated Research Ethics Board (#15–204); McGill University Health Centre (MP-CUSM-14-531-PED); University of Saskatchewan (#15–21); University of Alberta (PRO00055303). Participants signified their consent by submitting the survey.
: Not Applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.